InMed Pharmaceuticals Inc INM:NASDAQ

RT Quote | NASDAQ | USD
Last | 03/05/21 EST
4.11quote price arrow down-0.08 (-1.91%)
Volume
96,946
52 week range
2.95 - 10.43

...

Loading . . .

KEY STATS

  • Open4.25
  • Day High4.41
  • Day Low4.02
  • Prev Close4.19
  • 52 Week High10.43
  • 52 Week High Date06/04/20
  • 52 Week Low2.95
  • 52 Week Low Date12/17/20
  • Market Cap30.44M
  • Shares Out7M
  • 10 Day Average Volume0.14M
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-44.9

RATIOS/PROFITABILITY

  • EPS (TTM)-1.38
  • P/E (TTM)-2.97
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest InMed Pharmaceuticals Inc News

There is no recent news for this security.

Latest INM News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
InMed Pharmaceuticals Inc. is a pre-clinical-stage biopharmaceutical company. The Company specializes in the research and development of cannabinoid-based therapies combined with drug delivery systems. The Company operates through the segment of research and development of pharmaceutical cannabis based-therapies. The Company is working on two products, which include INM-750, for the treatment of Epidermolysis Bullosa (EB), and INM-085, for the treatment of Glaucoma. The...
William Garner M.D.
Chairman
Eric Adams
President
Bruce Colwill CPA
Chief Financial Officer
Michael Woudenberg
Vice President
Address
SUITE 310, 815 W. HASTINGS STREET
Vancouver, BC
V6C 1B4
Canada